Skip to main content
. 2019 Jun 1;9(5):e025117. doi: 10.1136/bmjopen-2018-025117

Table 2.

Secondary outcomes of interest

Endpoint and definitions Data source
Mortality outcomes
 Inpatient mortality Hospital record
Dialysis outcomes
 Inpatient dialysis Order entry system
 Discharged on dialysis Social work records
Renal failure outcomes
 Percent who progress to Stage 2 AKI Laboratory values
 Percent who progress to Stage 3 AKI Laboratory values
 Duration of AKI Laboratory values
Readmission rate and costs
 30-day readmission rate Hospital record
 Cost of index hospitalisation Billing records
Individual ‘Best Practice’ outcomes (proportion achieved per patient in study arm during index hospitalisation)
 Contrast administration Order entry system
 Fluid administration Order entry system
 Aminoglycoside administration Order entry system
 NSAID administration/cessation Order entry system
 ACE inhibitor administration/cessation Order entry system
 Urinalysis order Order entry system
 Documentation of AKI Postdischarge ICD-10 codes
 Monitoring of creatinine Order entry system
 Monitoring of urine output Hospital Record
 Renal consult Direct chart review
Provider awareness outcomes
 Chart documentation of AKI (by post discharge ICD-10 codes) Billing records
 Chart documentation of AKI (adjudicated) Direct chart review

ACE, angiotensin converting enzyme; AKI, acute kidney injury; NSAID, non-steroidal anti-inflammatory drug.